New Harbor Capital Portfolio Company Access Infusion Care Hires CXO

New Harbor Capital is excited to announce that portfolio company Access Infusion Care (“AIC”, “the Company”) has hired Greg Kaniecki as CXO.

Access Infusion Care is a diversified specialty and infusion pharmacy services provider focused on providing high-quality infusion therapies for patients in the home and suite settings. The Company was formed in January 2024 through the acquisition of AIC North and JLS Infusion Nurse Staffing Services and seeks to acquire high-quality infusion providers in underserved geographies with diversified therapy offerings and delivery settings and outsized growth potential.

New Harbor Capital’s newly launched CXO program connects high-achieving professionals (most often shortly after an MBA degree) with companies within our portfolio. Program participants are full-time employees of the portfolio company and a member of the senior management team. Responsibilities vary but include strategic projects supporting the Company’s growth. This mutually beneficial program offers participants valuable mentorship and professional experience while equipping portfolio companies with a critical resource to drive growth.

“We’re excited to see Greg take on this unique and new leadership role at Access Infusion Care,” said Bo Mlnarik, Principal at New Harbor Capital. “Greg was an excellent Associate and made significant contributions while a member of the New Harbor team. We are glad to be continuing our relationship with him and expect great things from him joining a portfolio company team in the CXO capacity.” 

“We’re very excited to welcome Greg as our CXO,” said Bruce Kutinsky, CEO of Access Infusion Care. “His proven track record in finance, corporate development, and business strategy, coupled with his extensive understanding of the specialty and home infusion space developed during his time at New Harbor, make him a perfect fit for our leadership team. We believe his comprehensive experience and insights will be instrumental in driving our company forward, helping us execute our strategy, achieve our mission, and fulfill our vision.”

Greg Kaniecki, CXO of Access Infusion Care

Greg Kaniecki brings diverse financial expertise to his role as CXO of Access Infusion Care. Most recently, Greg was a member of New Harbor Capital’s Investment team, where he assisted in evaluating and executing new investment opportunities in addition to working with New Harbor’s portfolio companies.

Previously, he was an Analyst in Houlihan Lokey’s financial restructuring group, where he helped advise companies, lenders, and other constituents on a broad range of strategic alternatives both in and out of court, including M&A, restructurings, liability management, and financing transactions.

Greg earned his BBA in Finance with a Supplementary Major in Economics from the University of Notre Dame.

About Access Infusion Care

Access Infusion Care is a diversified specialty and infusion pharmacy services provider focused on providing high-quality infusion therapies for patients in the home and suite settings. The Company was formed in January 2024 through the acquisition of AIC North and JLS Infusion Nurse Staffing Services and seeks to acquire high-quality infusion providers in underserved geographies with diversified therapy offerings and delivery settings and outsized growth potential.